Amgen Inc. (NASDAQ:AMGN) is one of the 10 Most Profitable S&P 500 Stocks to Buy Now. On March 19, 2026, Wells Fargo raised ...

In this article, we will look at the 10 Most Profitable S&P 500 Stocks to Buy Now. Profitability has moved back to the center ...

The White House’s direct-to-consumer (DTC) platform, TrumpRx, is steadily expanding its catalogue, with products from GSK and Amgen the latest to join the collection of drugs offered through the pr | ...

The Irish arm of bio-pharmaceutical giant Amgen has invested $407m (€353.3m) on capital expenditure on its Dun Laoghaire ...

Amgen Inc. (NASDAQ:AMGN) is one of the 10 best stocks to invest in during a recession. On February 27, 2026, Amgen Inc. (NASDAQ:AMGN)’s Phase 3 study (NCT05907122) saw an update. The study ...

Amgen Inc. and GSK plc are reportedly set to announce their partnership with TrumpRx.gov. This collaboration is set to offer ...

Why Amgen (AMGN) is on investors’ radar today Amgen (AMGN) is back in focus after recent share price moves, with the stock ...

Amgen stock soared as much as 16% on Friday after it reported first-quarter earnings. The company talked up its experimental GLP-1 weight-loss drug, MariTide. The new weight loss drug could be ...

Amgen is scrapping an experimental weight loss pill but moving forward with an injection. Amgen will release initial data from a mid-stage study on its injectable drug later this year, and the company ...

Amgen (AMGN) closed at $361.13 in the latest trading session, marking a -1.4% move from the prior day. This change lagged the ...

Amgen’s quarterly profit slid 1% but its revenue jumped 22%, according to its latest earnings report released Thursday afternoon. For the quarter, Amgen recorded $7.4 billion in revenue, thanks ...

A U.S. lawmaker is accusing Amgen of “putting profits before patients” over its decision to continue marketing a high dose of a pricey cancer treatment instead of a lower dose that is less expensive ...